• In recent days, Texas Instruments reported better-than-expected first-quarter results, highlighting strong analog revenue growth powered by industrial demand and a sharp rise in AI data center-related sales, while sector-wide optimism around semiconductors has been reinforced by broader index gains and supportive earnings across many chipmakers.
• At the same time, management’s emphasis on analog and embedded processing strengths, expanding internal manufacturing capacity, and upcoming investor outreach has sharpened attention on how Texas Instruments could benefit from AI infrastructure spending and industrial recovery trends within the semiconductor landscape.
• With renewed AI data center demand now firmly in focus, we’ll examine how this development may reshape Texas Instruments’ existing investment narrative.

Find 47 companies with promising cash flow potential yet trading below their fair value.

Texas Instruments Investment Narrative Recap

To own Texas Instruments, you need to believe its focus on analog and embedded chips in industrial, automotive and AI-related infrastructure can justify today’s higher valuation and ongoing heavy investment in new fabs. Recent AI data center strength and broad semiconductor rallies support the near term catalyst of industrial and AI-driven demand, but also heighten the main risk: large, long-lived manufacturing projects could be painful if sector momentum fades and capacity goes underused. So far, the news does not materially change that balance.

The clearest recent marker for this thesis is TI’s stronger than expected Q1 2026, where analog revenue rose 22% year over year with a 90% surge in data center-related sales. That print underpins current enthusiasm around AI infrastructure as a demand driver, while the upcoming Bernstein conference appearance gives management a platform to update how internal manufacturing, pricing actions and capital spending plans fit with that evolving story.

But while enthusiasm around AI and industrial recovery is understandable, investors should also be aware that rising capital expenditures and inventory levels could pressure free cash flow and margins over the next...

Texas Instruments' narrative projects $26.4 billion revenue and $10.3 billion earnings by 2029.

Uncover how Texas Instruments' forecasts yield a $280.62 fair value, a 9% downside to its current price.

Exploring Other Perspectives

Some of the lowest ranked analysts take a much tougher view than this, even before the latest AI-driven rally, assuming TI’s revenue reaches only about US$23.5 billion and earnings around US$7.4 billion by 2029, which helps explain why their risk narrative around oversupply, higher capex and weaker free cash flow looks far harsher than the more upbeat story tied to today’s AI and industrial headlines.

Explore 7 other fair value estimates on Texas Instruments - why the stock might be worth 34% less than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Texas Instruments research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Texas Instruments research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Texas Instruments' overall financial health at a glance.

Want Some Alternatives?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• The latest GPUs need a type of rare earth metal called Dysprosium and there are only 33 companies in the world exploring or producing it. Find the list for free.
• We've uncovered the 14 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.